Oculogica is the first highlight of the JAMA news section in this week’s issue: https://jamanetwork.com/journals/jama/fullarticle/2725217
Oculogica
Sofia Fund portfolio company Oculogica achieves FDA milestone
Oculogica receives FDA Marketing Authorization for EyeBOX®, the first non-invasive, baseline-free test for concussion. Oculogica is a pioneer in algorithm-based neurodiagnostics.
Looking Concussion in the Eye
A recent post in the April/ May Issue of MIT Review discusses the science Uzma Samadani used as she sought to find a way to measure improvements in her severely, brain-injured patients. The ability to capture a large amount of data from tracking not only eye movement but restrictions on range of motion in the eye led to the EyeBox product being developed by Oculogica, one of Sofia Fund’s portfolio companies.…
Getting a Read on Brain Function
Very interesting article in the StarTribune about HCMC’s neurosurgeon Dr. Uzma Samadani and the technology she is developing to assess brain function in real time. The technology is licensed to Oculogica, a company she co-founded, and is embodied in their device called the Eyebox.…